Understanding the role of Th17 in viral infections could help to predict clinical outcomes and even improve patient treatment since the blockade of the cytokine IL-17 or IL-17-induced pathways represents an important new therapeutic approach towards viral diseases [63,64]. This evidence concerns the gene IL17A and viral load.